Gangnam Severance Hospital
| Republic of Korea | Turkey | Austria | |
| NanoKnife | from $17,500 | from $9,500 | from $25,000 |
| CyberKnife | from $11,500 | from $4,750 | from $50,000 |
| Enucleation of tumor on pancreas | - | from $10,000 | - |
| Actinium-225 Therapy | - | from $22,955 | from $55,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Pancreatic neuroendocrine tumors treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pancreatic neuroendocrine tumors treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pancreatic neuroendocrine tumors treatment journey.
Dr. Kim Jin is a colorectal surgeon at Korea University Anam Hospital in Seoul. He is the Vice President of the Korean Association of Robotic Surgeons. Dr. Kim represents South Korea on the board of the Asia Pacific Endo-Lap Surgery Group. He performs surgical demonstrations for medical faculties in Hong Kong and Singapore.
Top medical centers for pancreatic neuroendocrine tumor treatment in South Korea include Severance Hospital and Korea University Anam Hospital. These JCI-accredited facilities offer advanced pancreatic enucleation and multidisciplinary care. Most centers utilize robotic surgery and advanced imaging to ensure precise tumor removal and preservation of organ function.
Bookimed Expert Insight: Korea University Anam Hospital is a strategic choice for high-precision cases. They pioneered robotic surgery methods and emphasize bloodless procedures. This approach significantly reduces infection risks and shortens recovery time for pancreatic patients. Their volume of 1.3 million annual patients suggests deep experience in managing complex oncology cases.
Patient Consensus: Patients note it is vital to secure a pathology second opinion for Ki-67 grading. High-volume university hospitals in Seoul are preferred for their specialized multidisciplinary tumor boards.
Treatment for pancreatic neuroendocrine tumors in South Korea involves multidisciplinary care at JCI-accredited university hospitals. Options include da Vinci robotic surgery, peptide receptor radionuclide therapy (PRRT), and targeted drug treatments. Specialists focus on tumor grade and Ki-67 index to determine precise surgical or systemic protocols.
Bookimed Expert Insight: Korea University Anam Hospital utilizes bloodless surgery protocols to minimize infection risks during complex tumor resections. This is particularly valuable for pNET patients undergoing major pancreatic surgery. Their multidisciplinary teams integrate pathology and oncology to refine treatment plans after reviewing Ki-67 indexes.
Patient Consensus: Patients note that getting a detailed pathology report with the Ki-67 index is essential before surgery. Many emphasize that university hospitals coordinate specialist input faster than smaller clinics.
South Korean outcomes for pancreatic neuroendocrine tumors are excellent. Five-year survival rates exceed 80% for local cohorts. Large JCI-accredited tertiary centers achieve 10-year survival rates near 90% for small nonfunctioning tumors. These results match or exceed international standards found in Western Europe and North America.
Bookimed Expert Insight: Patient volume is a reliable indicator of outcomes in Seoul. Severance Hospital alone manages 1.6 million outpatients annually. Our data suggests this massive scale allows surgeons to specialize specifically in rare neuroendocrine variants rather than general pancreatic care. This volume-driven expertise likely contributes to Korea's high 93% recurrence-free survival rates.
Patient Consensus: Patients emphasize finding the highest-volume specialist rather than just a reputable hospital. They frequently praise the speed of Korean centers where workups and surgery scheduling happen much faster than in Western systems.
South Korean hospitals offer robot-assisted pancreatic surgery for pancreatic neuroendocrine tumors (pNETs). Specialized oncology centers in Seoul utilize the Da Vinci system and the domestic Revo-i platform. These systems allow for precise tumor removal, including procedures like pancreaticoduodenectomy and distal pancreatectomy.
Bookimed Expert Insight: Korea University Anam Hospital stands out for its high-volume robotic expertise. This clinic reports serving over 1,300,000 patients annually. Their surgeons specifically focus on robotic excellence in cancer surgery. This high volume often correlates with better technical precision in complex pancreatic resections.
Patient Consensus: Patients emphasize that the surgeon's specific experience with pancreatic cases is more important than the robot itself. They note that while robotic surgery leaves smaller scars, the recovery remains serious due to potential drainage requirements.
Management of advanced pancreatic neuroendocrine tumors in Korea involves a multidisciplinary approach. Specialized oncology centers utilize systemic therapies, such as everolimus and sunitinib, alongside targeted radionuclides. JCI-accredited facilities offer localized treatments like CyberKnife stereotactic radiosurgery and NanoKnife irreversible electroporation for complex metastases.
Bookimed Expert Insight: Korea is a high-volume hub. Centers like Severance Hospital serve 4 million patients yearly. This massive patient volume allows Korean specialists to manage rare cases including complex pNETs with high proficiency. Their expertise is consistently recognized in Newsweek's World's Best Hospitals rankings.
Patient Consensus: Patients emphasize the need for detailed pathology, specifically checking Ki-67 levels and receptor status. Confirming somatostatin-receptor positivity is a vital step before starting advanced radionuclide therapies.
Major Korean tertiary centers including Asan Medical Center, Seoul National University Hospital, and Samsung Medical Center provide Lutetium-177 DOTATATE PRRT for pancreatic neuroendocrine tumors. These JCI-accredited facilities utilize nuclear medicine departments to deliver targeted radiation. Treatment typically follows progression on somatostatin analogs.
Bookimed Expert Insight: Korea University Anam Hospital and Severance Hospital serve over 1,300,000 and 1,600,000 patients annually. This massive patient volume allows these centers to maintain dedicated multidisciplinary teams for rare conditions like pNETs. JCI-accredited hubs often centralize nuclear medicine, so treatment availability is highest in Seoul-based university hospitals.
Patient Consensus: Patients note it is important to confirm the nuclear medicine department actually performs PRRT dosing. Some centers provide the diagnostic DOTATATE scans but refer the actual treatment to larger national hubs.
Surgical resection is the primary treatment for localised pancreatic neuroendocrine tumours in South Korea. Specialist surgeons use techniques such as enucleation or the Whipple procedure to remove tumours. Advanced cases may involve systemic therapies. These include somatostatin analogues, targeted drugs, and peptide receptor radionuclide therapy.
Bookimed Expert Insight: Many centres offer general oncology. However, Korea University Anam Hospital provides same-day consultations for new cancer patients. This speed is a significant advantage for Australians seeking rapid staging of neuroendocrine tumours. Their expertise in bloodless surgery options also caters to complex cases. In these cases, traditional resection carries higher risks.
Patient Consensus: Patients in the Republic of Korea find that surgery remains the main curative path. It is the main treatment for localised tumours. Many note that recurring cases often benefit from peptide receptor radionuclide therapy. It is typically combined with monthly octreotide injections.
South Korea offers Peptide Receptor Radionuclide Therapy (PRRT) for advanced pancreatic neuroendocrine tumours. Leading Seoul hospitals provide 177Lu-DOTATATE treatments for somatostatin receptor-positive tumours. Expert consensus in Korea supports PRRT as a standard option for metastatic cases with high survival rates.
Bookimed Expert Insight: Korea University Anam Hospital provides same-day consultations and admission for new cancer patients. This speed is vital for international patients starting PRRT. Most Seoul centres, including Gangnam Severance, offer free interpreters. This helps Australians navigate the complex radiation safety protocols required after treatment.
Patient Consensus: Patients note PRRT requires strict radiation precautions at home, such as sleeping alone for several days. They emphasise finding neuroendocrine specialists as general oncologists may be less familiar with radionuclide protocols in South Korea.
South Korean university hospitals are world leaders in treating functional pancreatic neuroendocrine tumours. Major Seoul centres perform thousands of oncology operations annually. They use robotic surgery and therapies like CyberKnife to manage hormone-producing tumours such as insulinomas. Most facilities hold JCI accreditation.
Bookimed Expert Insight: South Korea's advantage lies in its extreme surgical volume and early adoption of robotic systems. Gangnam Severance Hospital was Asia's first to use the da Vinci system for minimally invasive work. With long-term experience, their surgical teams handle postoperative complications more effectively than lower-volume centres. Patients with rare functional tumours benefit from this refined technical expertise.
Patient Consensus: Patients note that major Seoul university hospitals provide fantastic care for serious cancers. They recommend choosing a high-volume specialist centre in South Korea. This means the surgical team has extensive experience with neuroendocrine cases.
South Korea provides pancreatic neuroendocrine tumour (pNET) care through JCI-accredited high-volume centres. Patients access specialised therapies like Peptide Receptor Radionuclide Therapy (PRRT) and robotic surgery. Multidisciplinary teams manage complex cases. These centres offer rapid coordination with same-day consultations and tests.
Bookimed Expert Insight: South Korean clinics specialise in conversion surgery for previously unresectable tumours. Gangnam Severance Hospital was first in Asia to use robotic systems for such complex cases. This approach allows surgeons to remove tumours that other hospitals might consider inoperable.
Patient Consensus: Patients in the Republic of Korea report significant quality-of-life gains. These include improved energy and relief from diarrhoea. They emphasise that halting tumour growth is a successful outcome even without immediate shrinkage.